Thermo Fisher Scientific Inc (NYSE: TMO) has a higher price-to-earnings ratio of 31.44x compared to its average ratio. TMO has 36-month beta value of 0.78. Analysts have mixed views on the stock, with 16 analysts rating it as a “buy,” 8 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for TMO is 381.90M, and currently, short sellers hold a 0.77% ratio of that float. The average trading volume of TMO on November 19, 2024 was 1.29M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
TMO) stock’s latest price update
The stock of Thermo Fisher Scientific Inc (NYSE: TMO) has decreased by -2.30 when compared to last closing price of 513.08. Despite this, the company has experienced a -8.34% fall in its stock price over the last five trading sessions. businesswire.com reported 2024-11-15 that WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. This replaces the company’s existing repurchase authorization, of which $1 billion was remaining. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world lead.
TMO’s Market Performance
Thermo Fisher Scientific Inc (TMO) has seen a -8.34% fall in stock performance for the week, with a -16.69% decline in the past month and a -18.43% plunge in the past quarter. The volatility ratio for the week is 2.29%, and the volatility levels for the past 30 days are at 2.05% for TMO. The simple moving average for the past 20 days is -8.78% for TMO’s stock, with a -13.32% simple moving average for the past 200 days.
Analysts’ Opinion of TMO
Stephens, on the other hand, stated in their research note that they expect to see TMO reach a price target of $680. The rating they have provided for TMO stocks is “Overweight” according to the report published on October 01st, 2024.
Wells Fargo gave a rating of “Overweight” to TMO, setting the target price at $670 in the report published on August 28th of the current year.
TMO Trading at -14.17% from the 50-Day Moving Average
After a stumble in the market that brought TMO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.16% of loss for the given period.
Volatility was left at 2.05%, however, over the last 30 days, the volatility rate increased by 2.29%, as shares sank -15.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -19.20% lower at present.
During the last 5 trading sessions, TMO fell by -8.34%, which changed the moving average for the period of 200-days by -9.16% in comparison to the 20-day moving average, which settled at $549.52. In addition, Thermo Fisher Scientific Inc saw -5.56% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TMO starting from CASPER MARC N, who sale 9,000 shares at the price of $552.86 back on Nov 08 ’24. After this action, CASPER MARC N now owns 14,608 shares of Thermo Fisher Scientific Inc, valued at $4,975,765 using the latest closing price.
CASPER MARC N, the Officer of Thermo Fisher Scientific Inc, proposed sale 9,000 shares at $552.86 during a trade that took place back on Nov 08 ’24, which means that CASPER MARC N is holding shares at $4,975,753 based on the most recent closing price.
Stock Fundamentals for TMO
Current profitability levels for the company are sitting at:
- 0.17 for the present operating margin
- 0.41 for the gross margin
The net margin for Thermo Fisher Scientific Inc stands at 0.14. The total capital return value is set at 0.08. Equity return is now at value 13.01, with 6.22 for asset returns.
Based on Thermo Fisher Scientific Inc (TMO), the company’s capital structure generated 0.42 points at debt to capital in total, while cash flow to debt ratio is standing at 0.26. The debt to equity ratio resting at 0.72. The interest coverage ratio of the stock is 4.9.
Currently, EBITDA for the company is 10.8 billion with net debt to EBITDA at 2.71. When we switch over and look at the enterprise to sales, we see a ratio of 5.25. The receivables turnover for the company is 4.33for trailing twelve months and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.63.
Conclusion
To put it simply, Thermo Fisher Scientific Inc (TMO) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
